InsidersTradesSigma
Follow the 인벤테라 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 인벤테라 has logged 1 insider filings. Market capitalisation: €60.6bn. The latest transaction was reported on 7 April 2026 (Purchase). Among the most active insiders: 유안타케이바이오백신블록버스터사모투자. Every trade is openly available.
1
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
n/a
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 April 2026
Declarations1 total
368,412 sharesKRXDART:20260407003267
1 of 1 declaration
Acerca de 인벤테라
Inventaera es una empresa de salud y farmacéutica que cotiza en el mercado XKRX. Se enfoca en desarrollar soluciones innovadoras para mejorar la atención médica.